חזרה לתוצאות החיפוש

A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE1, PHASE2

מצבים רפואיים

Locally Advanced Solid Tumors · Metastatic Solid Tumors

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים

  • Local Institution - 2129, Duarte, California, United States

  • Local Institution - 2120, Glendale, California, United States

  • Local Institution - 2136, La Jolla, California, United States

  • Local Institution - 2114, La Jolla, California, United States

  • Local Institution - 2121, Long Beach, California, United States

  • Local Institution - 1001, Orange, California, United States

  • Local Institution - 2101, Orange, California, United States

  • St Joseph Heritage Healthcare, Santa Rosa, California, United States

    Contact: Study coordinator (Ian Anderson)

  • Local Institution - 1003, Aurora, Colorado, United States

  • Local Institution - 2103, Aurora, Colorado, United States

  • Local Institution - 2106, Washington D.C., District of Columbia, United States

  • Local Institution - 2110, Washington D.C., District of Columbia, United States

  • Memorial Healthcare System, Hollywood, Florida, United States

    Contact: Study coordinator (Luis Raez) · 954-265-4325

  • Local Institution - 2113, Tampa, Florida, United States

  • University Cancer and Blood Center, Athens, Georgia, United States

    Contact: Study coordinator (PETROS NIKOLINAKOS) · 706-353-2990

  • Local Institution - 2134, Columbus, Georgia, United States

  • University of Chicago, Chicago, Illinois, United States

    Contact: Study coordinator (Christine Bestvina) · 773-702-4400

  • Local Institution - 2142, Peoria, Illinois, United States

  • Local Institution - 2116, New Orleans, Louisiana, United States

  • Local Institution - 2133, Baltimore, Maryland, United States

  • Massachusetts General Hospital,, Boston, Massachusetts, United States

    Contact: Study coordinator (Jessica Lin) · 617-724-4000

  • Local Institution - 1004, Boston, Massachusetts, United States

  • Local Institution - 2131, Boston, Massachusetts, United States

  • Local Institution - 2105, Ann Arbor, Michigan, United States

  • Local Institution - 2111, Detroit, Michigan, United States

  • Local Institution - 2140, Detroit, Michigan, United States

  • Local Institution - 2132, Saint Paul, Minnesota, United States

  • Local Institution - 2147, Bolivar, Missouri, United States

  • Washington University Infusion Center Pharmacy, St Louis, Missouri, United States

    Contact: Study coordinator (Brian Van Tine) · 314-747-3096

  • Local Institution - 2122, New Brunswick, New Jersey, United States

  • Local Institution - 2117, New York, New York, United States

  • Local Institution - 1002, New York, New York, United States

  • Local Institution - 2102, New York, New York, United States

  • Local Institution - 2144, Goldsboro, North Carolina, United States

  • Local Institution - 2112, Canton, Ohio, United States

  • Local Institution - 2143, Cincinnati, Ohio, United States

  • Local Institution - 2109, Cleveland, Ohio, United States

  • The Ohio State University Wexner Medical Center, Columbus, Ohio, United States

    Contact: Study coordinator (Dwight Owen) · 614-293-6401

  • Local Institution - 2119, Toledo, Ohio, United States

  • Local Institution - 2108, Philadelphia, Pennsylvania, United States

  • Baptist Memorial Hospital Baptist Cancer Center, Memphis, Tennessee, United States

    Contact: Study coordinator (Philip Lammers)

  • UT Southwestern Medical Center, Dallas, Texas, United States

    Contact: Study coordinator (Syed Kazmi) · 214-648-5368

  • Local Institution - 2127, Houston, Texas, United States

  • MD Anderson Cancer Center, Houston, Texas, United States

    Contact: Study coordinator (George Blumenschein Jr) · 713-792-6363

  • Local Institution - 2146, Kingwood, Texas, United States

  • Local Institution - 2137, Fairfax, Virginia, United States

  • Local Institution - 2107, Seattle, Washington, United States

  • Local Institution - 2141, Tacoma, Washington, United States

  • Local Institution - 2145, Appleton, Wisconsin, United States

  • Chris O'Brien LifeHouse, Camperdown, New South Wales, Australia

    Contact: Study coordinator (Steven Kao) · 61295157403

  • Local Institution - 6103, Adelaide, South Australia, Australia

  • Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia

    Contact: Study coordinator (Ben Solomon) · 61385595000

  • Local Institution - 3301, East Melbourne, Australia

  • Local Institution - 4802, Antwerp, Belgium

  • Local Institution - 4801, Leuven, Belgium

  • Local Institution - 2202, Edmonton, Alberta, Canada

  • Local Institution - 2205, Vancouver, British Columbia, Canada

  • Local Institution - 2201, Toronto, Ontario, Canada

  • Local Institution - 6503, Toronto, Ontario, Canada

  • Local Institution - 2203, Ontario, Canada

  • Local Institution - 2204, Ottawa, Canada

  • Local Institution - 6702, Beijing, Beijing Municipality, China

  • Beijing Cancer hospital, Beijing, Beijing Municipality, China

    Contact: Study coordinator (Jian Fang) · 868613701224460

  • Daping Hospital, the Third Affiliated Hospital of Third Military Medical University /Cancer Center, Daping, Chongqing Municipality, China

    Contact: Study coordinator (Yong He) · 13908338998

  • Local Institution - 6719, Fuzhou, Fujian, China

  • The First Affiliated hospital of Xiamen University-oncology, Xiamen, Fujian, China

    Contact: Study coordinator (Jingxun Wu) · 15160085395

  • Guangdong Provincial People'S Hospital, Guangzhou, Guangdong, China

    Contact: Study coordinator (Jinji Yang)

  • Local Institution - 6733, Guangzhou, Guangdong, China

  • Local Institution - 6505, Shenzhen, Guangdong, China

  • The Affiliated Tumor Hospital of Harbin Medical University, Harbin, Heilongjiang, China

    Contact: Study coordinator (Yan Yu) · 13904505825

  • Local Institution - 6504, Shatin, HONG KONG, China

  • Local Institution - 6710, Wuhan, Hubei, China

  • Local Institution - 6705, Changsha, Hunan, China

  • Hunan Cancer Hospital-thoracic oncology II, Changsha, Hunan, China

    Contact: Study coordinator (Nong Yang) · 13055193557

  • Local Institution - 6748, Nanjing, Jiangsu, China

  • XuZhou Central Hospital/Oncology Department, Xuzhou, Jiangsu, China

    Contact: Study coordinator (Xiang Wang)

  • Jilin Cancer Hospital/Medical Oncology Department, Changchun, Jilin, China

    Contact: Study coordinator (Meili Sun) · 18953116532

  • Jilin Cancer Hospital/Medical Oncology Department, Changchun, Jilin, China

    Contact: Study coordinator (Ying Cheng) · 8613943012851

  • The first hospital of Jilin university-Oncology Department, Changchun, Jilin, China

    Contact: Study coordinator (Jiuwei Cui) · 8615843073215

  • Liaoning Cancer Hospital, Shenyang, Liaoning, China

    Contact: Study coordinator (Rui Ma)

  • Tangdu Hospital, Xi'an, Shan3xi, China

    Contact: Study coordinator (Haichuan Su)

  • Shanxi Bethune Hospital, Taiyuan, Shanxi, China

    Contact: Study coordinator (Junping Zhang) · 13994204099

  • Sichuan Cancer Hospital/Medical Oncology Department, Chengdu, Sichuan, China

    Contact: Study coordinator (Wenxiu Yao) · 18908178836

  • The First Hospital Affiliated To AMU - Southwest Hospital, Chongqing, Sichuan, China

    Contact: Study coordinator (Liang Gong) · +8613983965893

  • Local Institution - 6725, Hangzhou, Zhejiang, China

  • Zhejiang Cancer Hospital-Oncology, Hangzhou, Zhejiang, China

    Contact: Study coordinator (Yiping Zhang)

  • The Third Xiangya Hospital of Central South University/Department of Respiratory and Critical Care Medicine, Changsha, China

    Contact: Study coordinator (Jie Meng)

  • West China Hospital Sichuan University/Lung cancer center, Chengdu, China

    Contact: Study coordinator (Feng Luo) · +8618980601766

  • The First Affiliated Hospital - Zhejiang University School of Medicine, Hangzhou, China

    Contact: Study coordinator (Jianying Zhou) · 8613505719970

  • Anhui Provincial Hospital, Hefei, China

    Contact: Study coordinator (Yueyin Pan) · 8613805695536

  • Shanghai Chest Hospital, Shanghai, China

    Contact: Study coordinator (Liyan Jiang)

  • Shanghai Chest Hospital, Shanghai, China

    Contact: Study coordinator (Shun Lu) · 8613601813062

  • Weifang People's Hospital/Medical Oncology Department, Weifang, China

    Contact: Study coordinator (Guohua Yu)

  • Henan Cancer Hospital/The 1st pneumology department, Zhengzhou, China

    Contact: Study coordinator (Xiufeng Hu) · +8618339920984

  • Local Institution - 4901, Copenhagen, Denmark

  • Local Institution - 4201, Marseille, Bouches-du-Rhône, France

  • Local Institution - 4207, Brest, France

  • Centre Georges-Francois Leclerc, Dijon, France

    Contact: Study coordinator (Alice Hervieu) · 33380737506

  • Centre Hospitalier Universitarie Grenoble Alpes (Chuga), Grenoble, France

    Contact: Study coordinator (Denis Moro-Sibilot) · 33476768708

  • Centre Antoine-Lacassagne, Nice, France

    Contact: Study coordinator (Esma Saada-Bouzid) · 33492031514

  • Local Institution - 4208, Poitiers, France

  • Local Institution - 4203, Saint-Mandé, France

  • Institute Gustave Roussy, Villejuif, France

    Contact: Study coordinator (Benjamin Besse) · 33142114211

  • Local Institution - 4704, Berlin, Germany

  • Local Institution - 4701, Cologne, Germany

  • Local Institution - 4703, Dresden, Germany

  • Local Institution - 4702, Heidelberg, Germany

  • Local Institution - 6502, Hong Kong, Hong Kong

  • Local Institution - 6501, Hong Kong, Hong Kong

  • Local Institution - 5101, Budapest, Hungary

  • Local Institution - 5103, Budapest, Hungary

  • Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, MI, Italy

    Contact: Study coordinator (Roberto Ferrara) · 390223903829

  • Local Institution - 4306, Milan, Italy

  • Local Institution - 4307, Palermo, Italy

  • Centro di Riferimento Oncologico, Pordenone, Italy

    Contact: Study coordinator (Alessandra Bearz) · 390434659294

  • Local Institution - 4304, Ravenna, Italy

  • Local Institution - 4305, Reggio Emilia, Italy

  • IRCCS Istituto Regina Elena Oncologia Medica 2, Roma, Italy

    Contact: Study coordinator (Federico Capuzzo) · +390516225126

  • Local Institution - 4302, Terni, Italy

  • Ehime University Hospital, Tōon, Ehime, Japan

    Contact: Study coordinator (Naoyuki Nogami) · +81-89-960-5994

  • Hokkaido University Hospital, Sapporo, Hokkaido, Japan

    Contact: Study coordinator (Jun Sakakibara) · +81-11-716-1161

  • Kanagawa cancer center, Yokohama, Kanagawa, Japan

    Contact: Study coordinator (Kato Terufumi) · +8145520222200000000

  • Osaka City General Hospital, Osaka, Osaka, Japan

    Contact: Study coordinator (Haruko Daga) · 81669293269

  • National Cancer Center Hospital., Chuo-ku, Tokyo, Japan

    Contact: Study coordinator (Yasushi Goto) · +819043996497

  • Tottori University Hospital, Yonago, Tottori, Japan

    Contact: Study coordinator (Kodani Masahiro)

  • National Cancer Center Hospital East, Kashiwa, Japan

    Contact: Study coordinator (Koichi Goto) · 81471331111

  • Nagoya University Hospital, Nagoya, Japan

    Contact: Study coordinator (Yuichi Ando) · 81527412111

  • Osaka International Cancer institute, Osaka, Japan

    Contact: Study coordinator (Motohiro 基裕 Tamiya 田宮) · 81669451181

  • Local Institution - 4502, Amsterdam, Netherlands

  • Local Institution - 4501, Groningen, Netherlands

  • Ośrodek Badań Klinicznych Wczesnych Faz, Uniwersyteckie Centrum Kliniczne, Gdansk, Poland

    Contact: Study coordinator (Rafal Dziadziuszko) · 48585844571

  • Local Institution - 4604, Lublin, Poland

  • Local Institution - 4605, Poznan, Poland

  • Local Institution - 4603, Szczecin, Poland

  • Local Institution - 4602, Warsaw, Poland

  • National University Hospital, Singapore, Singapore

    Contact: Study coordinator (Ross Soo) · 000-000-0000

  • National Cancer Center Singapore, Singapore, Singapore

    Contact: Study coordinator (Wan Teck Darren Lim) · 656564368000

  • Local Institution - 3003, Seoul, Gangnam-gu, South Korea

  • Chonnam National University Hwasun Hospital, Hwasun-eup, Hwasun-gun, Jeollanam-do, South Korea

    Contact: Study coordinator (Young-Chul Kim)

  • Local Institution - 3002, Seoul, Seodaemun-gu, South Korea

  • Local Institution - 3002, Seoul, Seoul Teugbyeolsi, South Korea

  • Seoul National University Hospital, Seoul, Seoul-teukbyeolsi [Seoul], South Korea

    Contact: Study coordinator (Dong-Wan Kim) · +821027324635

  • Samsung Medical Center, Seoul, Seoul-teukbyeolsi [Seoul], South Korea

    Contact: Study coordinator (Jung Yong Hong) · +82234103459

  • Local Institution - 6306, Cheongju-si, South Korea

  • Local Institution - 3001, Seoul, South Korea

  • Yonsei University Health System, Severance Hospital, Seoul, South Korea

    Contact: Study coordinator (Byoung Chul Cho) · 82222288126

  • Local Institution - 6307, Seoul, South Korea

  • Asan Medical Center, Seoul, South Korea

    Contact: Study coordinator (Sang-We Kim) · 82230103215

  • Local Institution - 6304, Seoul, South Korea

  • Local Institution - 4102, Barcelona, Spain

  • Hospital Unversitario Val D'Hebrón, Barcelona, Spain

    Contact: Study coordinator (Enriqueta Felip)

  • Local Institution - 4106, Madrid, Spain

  • START Madrid-FJD, Madrid, Spain

    Contact: Study coordinator (Victor Moreno) · 34915504800272400

  • Local Institution - 4103, Madrid, Spain

  • Hospital Universitario HM Sanchinarro CIOCC, Madrid, Spain

    Contact: Study coordinator (Emiliano Calvo) · +34934894304

  • Local Institution - 4108, Pamplona, Spain

  • Local Institution - 4107, Valencia, Spain

  • Local Institution - 6201, Taiepi, Taiwan

  • Local Institution - 6203, Tainan, Taiwan

  • Local Institution - 6202, Taipei, Taiwan

  • Local Institution - 4401, London, United Kingdom

  • Local Institution - 4402, London, United Kingdom

  • Local Institution - 4404, London, United Kingdom

  • Local Institution - 4403, Manchester, United Kingdom

  • Local Institution - 4405, Sutton, United Kingdom

מובילי המחקר

  • Bristol-Myers Squibb

    Study Director

    Bristol-Myers Squibb

צפייה במקור ב־ClinicalTrials.gov(נפתח בחלון חדש)